Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Lucira Health, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 36 | 46 | +10 |
| Shares | 17.7M | 24.6M | +6.84M (+38.6%) |
| Value | $131.9M | $211.6M | +$79.8M (+60.5%) |
New holders (20)
Institutions that held Lucira Health, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eclipse Ventures, LLC | 6,223,795 | $53.6M | 8.95% |
| Data Collective II GP, LLC | 296,227 | $2.55M | 2.66% |
| Parian Global Management LP | 183,804 | $1.58M | 1.43% |
| Consilio Wealth Advisors, LLC | 97,518 | $840.0K | 0.65% |
| D. E. Shaw & Co., Inc. | 74,565 | $642.0K | 0.00% |
| Qube Research & Technologies Ltd | 64,729 | $557.0K | 0.00% |
| Atom Investors LP | 55,479 | $478.0K | 0.13% |
| 683 Capital Management, LLC | 41,629 | $358.0K | 0.02% |
| CastleKnight Management LP | 22,800 | $196.0K | 0.07% |
| Tudor Investment Corp Et Al | 15,629 | $135.0K | 0.00% |
| Paloma Partners Management Co | 13,084 | $113.0K | 0.00% |
| Man Group plc | 12,669 | $109.0K | 0.00% |
| ExodusPoint Capital Management, LP | 11,300 | $97.0K | 0.00% |
| Walleye Capital LLC | 10,915 | $94.0K | 0.00% |
| Bank of America Corp | 9,582 | $83.0K | 0.00% |
| Group One Trading, L.P. | 4,103 | $35.0K | 0.00% |
| JPMorgan Chase & Co | 463 | $4.00K | 0.00% |
| Snowden Capital Advisors LLC | 340 | $2.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 169 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% |
Sold out (10)
Institutions that held Lucira Health, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| MPM Oncology Impact Management LP | 578,114 | $4.39M |
| Board of Trustees of The Leland Stanford Junior University | 124,459 | $946.0K |
| Foresite Capital Management V, LLC | 485,000 | $760.0K |
| Balyasny Asset Management LLC | 93,439 | $710.0K |
| FMR LLC | 57,684 | $438.0K |
| Federated Hermes, Inc. | 27,487 | $209.0K |
| Ergoteles LLC | 15,331 | $117.0K |
| Needham Investment Management LLC | 13,672 | $104.0K |
| Signaturefd, LLC | 215 | $2.00K |
| US Bancorp | 40 | $0 |